mouse |
LD50 |
intraperitoneal |
510mg/kg (510mg/kg) |
lungs, thorax, or respiration: dyspnea |
Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 22, Pg. 1501, 1980. |
mouse |
LD50 |
intravenous |
500mg/kg (500mg/kg) |
|
Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 11, Pg. 811, 1980. |
mouse |
LD50 |
oral |
1310mg/kg (1310mg/kg) |
lungs, thorax, or respiration: dyspnea |
Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 22, Pg. 1501, 1980. |
mouse |
LD50 |
subcutaneous |
625mg/kg (625mg/kg) |
lungs, thorax, or respiration: dyspnea |
Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 22, Pg. 1501, 1980. |
rat |
LD50 |
intraperitoneal |
410mg/kg (410mg/kg) |
|
Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 11, Pg. 811, 1980. |
rat |
LD50 |
intravenous |
350mg/kg (350mg/kg) |
|
Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 11, Pg. 811, 1980. |
rat |
LD50 |
oral |
2450mg/kg (2450mg/kg) |
|
Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 11, Pg. 811, 1980. |
rat |
LD50 |
subcutaneous |
570mg/kg (570mg/kg) |
|
Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 11, Pg. 811, 1980. |